ZA200004654B - A convergent synthesis of α-aryl-β-ketonitriles. - Google Patents
A convergent synthesis of α-aryl-β-ketonitriles. Download PDFInfo
- Publication number
- ZA200004654B ZA200004654B ZA200004654A ZA200004654A ZA200004654B ZA 200004654 B ZA200004654 B ZA 200004654B ZA 200004654 A ZA200004654 A ZA 200004654A ZA 200004654 A ZA200004654 A ZA 200004654A ZA 200004654 B ZA200004654 B ZA 200004654B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- alkyl
- cycloalkyl
- cycloalkylalkyl
- compound
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title claims description 9
- 238000003786 synthesis reaction Methods 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims description 61
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 48
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 30
- 125000000217 alkyl group Chemical group 0.000 claims description 26
- 125000003342 alkenyl group Chemical group 0.000 claims description 21
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 18
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 18
- 125000000304 alkynyl group Chemical group 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 230000002140 halogenating effect Effects 0.000 claims description 16
- 238000006317 isomerization reaction Methods 0.000 claims description 16
- 125000000623 heterocyclic group Chemical group 0.000 claims description 15
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 14
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 14
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 14
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 13
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 11
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical group BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 150000003839 salts Chemical group 0.000 claims description 10
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 8
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical group 0.000 claims description 7
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 6
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims description 6
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical group [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 6
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 5
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical group IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 claims description 5
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical group [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 claims description 5
- 229910052740 iodine Inorganic materials 0.000 claims description 5
- 239000011630 iodine Substances 0.000 claims description 5
- -1 pyrrclidine Natural products 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 125000001188 haloalkyl group Chemical group 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 claims description 4
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 claims description 3
- AZVCGYPLLBEUNV-UHFFFAOYSA-N lithium;ethanolate Chemical compound [Li+].CC[O-] AZVCGYPLLBEUNV-UHFFFAOYSA-N 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 claims description 3
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical group [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 claims description 2
- CCZVEWRRAVASGL-UHFFFAOYSA-N lithium;2-methanidylpropane Chemical compound [Li+].CC(C)[CH2-] CCZVEWRRAVASGL-UHFFFAOYSA-N 0.000 claims description 2
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 claims description 2
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 claims description 2
- QCYIFDAFIXZTQO-UHFFFAOYSA-N lithium;diphenylmethylbenzene Chemical compound [Li+].C1=CC=CC=C1[C-](C=1C=CC=CC=1)C1=CC=CC=C1 QCYIFDAFIXZTQO-UHFFFAOYSA-N 0.000 claims description 2
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 claims description 2
- IQIWJEAPUNWDLC-UHFFFAOYSA-N lithium;octane Chemical compound [Li+].CCCCCCC[CH2-] IQIWJEAPUNWDLC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- MOFPNEADTSBYFQ-UHFFFAOYSA-N tributan-2-yl borate Chemical compound CCC(C)OB(OC(C)CC)OC(C)CC MOFPNEADTSBYFQ-UHFFFAOYSA-N 0.000 claims description 2
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 claims description 2
- AJSTXXYNEIHPMD-UHFFFAOYSA-N triethyl borate Chemical compound CCOB(OCC)OCC AJSTXXYNEIHPMD-UHFFFAOYSA-N 0.000 claims description 2
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 claims description 2
- LTEHWCSSIHAVOQ-UHFFFAOYSA-N tripropyl borate Chemical compound CCCOB(OCCC)OCCC LTEHWCSSIHAVOQ-UHFFFAOYSA-N 0.000 claims description 2
- LHJSLDBKUGXPMI-UHFFFAOYSA-N tris(2-methylpropyl) borate Chemical compound CC(C)COB(OCC(C)C)OCC(C)C LHJSLDBKUGXPMI-UHFFFAOYSA-N 0.000 claims description 2
- ZMCWFMOZBTXGKI-UHFFFAOYSA-N tritert-butyl borate Chemical compound CC(C)(C)OB(OC(C)(C)C)OC(C)(C)C ZMCWFMOZBTXGKI-UHFFFAOYSA-N 0.000 claims description 2
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical group COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 1
- 208000014797 chronic intestinal pseudoobstruction Diseases 0.000 claims 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 claims 1
- 102000012289 Corticotropin-Releasing Hormone Human genes 0.000 description 10
- 108010022152 Corticotropin-Releasing Hormone Proteins 0.000 description 10
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 10
- 150000002545 isoxazoles Chemical class 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- NFLDXKDDDKVRSN-UHFFFAOYSA-N 4-iodo-5-methyl-1,2-oxazole Chemical compound CC=1ON=CC=1I NFLDXKDDDKVRSN-UHFFFAOYSA-N 0.000 description 2
- AGQOIYCTCOEHGR-UHFFFAOYSA-N 5-methyl-1,2-oxazole Chemical compound CC1=CC=NO1 AGQOIYCTCOEHGR-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 238000006880 cross-coupling reaction Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002464 receptor antagonist Substances 0.000 description 2
- 229940044551 receptor antagonist Drugs 0.000 description 2
- ZMMOYIXZGHJMNI-UHFFFAOYSA-N 3-oxopropanenitrile Chemical compound O=CCC#N ZMMOYIXZGHJMNI-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000001543 aryl boronic acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- DBYQHFPBWKKZAT-UHFFFAOYSA-N lithium;benzene Chemical compound [Li+].C1=CC=[C-]C=C1 DBYQHFPBWKKZAT-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000000063 preceeding effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D201/00—Preparation, separation, purification or stabilisation of unsubstituted lactams
- C07D201/02—Preparation of lactams
- C07D201/08—Preparation of lactams from carboxylic acids or derivatives thereof, e.g. hydroxy carboxylic acids, lactones or nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8068098P | 1998-04-03 | 1998-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200004654B true ZA200004654B (en) | 2001-12-24 |
Family
ID=22158933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200004654A ZA200004654B (en) | 1998-04-03 | 2000-09-05 | A convergent synthesis of α-aryl-β-ketonitriles. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6107508A (da) |
| EP (1) | EP1066250B1 (da) |
| JP (1) | JP2002510670A (da) |
| KR (1) | KR20010042401A (da) |
| CN (1) | CN1296473A (da) |
| AT (1) | ATE289990T1 (da) |
| AU (1) | AU3213599A (da) |
| BR (1) | BR9909427A (da) |
| CA (1) | CA2326846C (da) |
| CZ (1) | CZ20003519A3 (da) |
| DE (1) | DE69923958T2 (da) |
| DK (1) | DK1066250T3 (da) |
| EA (1) | EA200001017A1 (da) |
| EE (1) | EE200000580A (da) |
| ES (1) | ES2235472T3 (da) |
| HU (1) | HUP0101798A3 (da) |
| IL (1) | IL138501A0 (da) |
| NO (1) | NO20004956L (da) |
| PL (1) | PL343610A1 (da) |
| PT (1) | PT1066250E (da) |
| SK (1) | SK14432000A3 (da) |
| WO (1) | WO1999051568A2 (da) |
| ZA (1) | ZA200004654B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562965B1 (en) * | 2000-07-06 | 2003-05-13 | Bristol-Myers Squibb Pharma Company | Convergent synthesis of α-aryl-β-ketonitriles |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6296479A (ja) * | 1985-10-23 | 1987-05-02 | Shionogi & Co Ltd | ポリフルオロアルキルイソオキサゾリルアミン類 |
-
1999
- 1999-03-29 KR KR1020007010973A patent/KR20010042401A/ko not_active Application Discontinuation
- 1999-03-29 ES ES99914246T patent/ES2235472T3/es not_active Expired - Lifetime
- 1999-03-29 IL IL13850199A patent/IL138501A0/xx unknown
- 1999-03-29 EA EA200001017A patent/EA200001017A1/ru unknown
- 1999-03-29 AU AU32135/99A patent/AU3213599A/en not_active Abandoned
- 1999-03-29 HU HU0101798A patent/HUP0101798A3/hu unknown
- 1999-03-29 PL PL99343610A patent/PL343610A1/xx not_active Application Discontinuation
- 1999-03-29 BR BR9909427-4A patent/BR9909427A/pt not_active IP Right Cessation
- 1999-03-29 EP EP99914246A patent/EP1066250B1/en not_active Expired - Lifetime
- 1999-03-29 CZ CZ20003519A patent/CZ20003519A3/cs unknown
- 1999-03-29 EE EEP200000580A patent/EE200000580A/xx unknown
- 1999-03-29 SK SK1443-2000A patent/SK14432000A3/sk unknown
- 1999-03-29 PT PT99914246T patent/PT1066250E/pt unknown
- 1999-03-29 WO PCT/US1999/006822 patent/WO1999051568A2/en active IP Right Grant
- 1999-03-29 JP JP2000542290A patent/JP2002510670A/ja active Pending
- 1999-03-29 AT AT99914246T patent/ATE289990T1/de not_active IP Right Cessation
- 1999-03-29 DK DK99914246T patent/DK1066250T3/da active
- 1999-03-29 DE DE69923958T patent/DE69923958T2/de not_active Expired - Fee Related
- 1999-03-29 CA CA002326846A patent/CA2326846C/en not_active Expired - Fee Related
- 1999-03-29 CN CN99804854A patent/CN1296473A/zh active Pending
- 1999-03-31 US US09/282,508 patent/US6107508A/en not_active Expired - Lifetime
-
2000
- 2000-09-05 ZA ZA200004654A patent/ZA200004654B/en unknown
- 2000-10-02 NO NO20004956A patent/NO20004956L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA200001017A1 (ru) | 2001-02-26 |
| HUP0101798A2 (hu) | 2001-11-28 |
| HUP0101798A3 (en) | 2003-03-28 |
| PT1066250E (pt) | 2005-05-31 |
| JP2002510670A (ja) | 2002-04-09 |
| BR9909427A (pt) | 2000-11-21 |
| PL343610A1 (en) | 2001-08-27 |
| WO1999051568A2 (en) | 1999-10-14 |
| KR20010042401A (ko) | 2001-05-25 |
| DE69923958D1 (de) | 2005-04-07 |
| CA2326846A1 (en) | 1999-10-14 |
| EP1066250B1 (en) | 2005-03-02 |
| NO20004956L (no) | 2000-11-01 |
| SK14432000A3 (sk) | 2001-09-11 |
| CZ20003519A3 (cs) | 2001-08-15 |
| ES2235472T3 (es) | 2005-07-01 |
| NO20004956D0 (no) | 2000-10-02 |
| US6107508A (en) | 2000-08-22 |
| WO1999051568A3 (en) | 1999-11-18 |
| EP1066250A2 (en) | 2001-01-10 |
| EE200000580A (et) | 2002-02-15 |
| DE69923958T2 (de) | 2006-04-06 |
| AU3213599A (en) | 1999-10-25 |
| CA2326846C (en) | 2009-02-03 |
| ATE289990T1 (de) | 2005-03-15 |
| DK1066250T3 (da) | 2005-06-06 |
| IL138501A0 (en) | 2001-10-31 |
| CN1296473A (zh) | 2001-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wen et al. | Ruthenium (ii)-catalyzed chemoselective deacylative annulation of 1, 3-diones with sulfoxonium ylides via C–C bond activation | |
| Hu et al. | Palladium-catalyzed ionic liquid-accelerated oxidative annulation of acetylenic oximes with unactivated long-chain enols | |
| Bi et al. | Ru-catalyzed direct amidation of carboxylic acids with N-substituted formamides | |
| Qiu et al. | Iodine promoted cascade cycloisomerization of 1-en-6, 11-diynes | |
| Yamada et al. | Asymmetric synthesis of sceletium alkaloids:(−)-mesembrine,(+)-sceletium A-4,(+)-tortuosamine and (+)-N-formyltortuosamine | |
| CN111808023B (zh) | 一种制备3-芳基异喹啉衍生物的方法 | |
| ZA200004654B (en) | A convergent synthesis of α-aryl-β-ketonitriles. | |
| CN115043788B (zh) | 一种三氟甲基噁唑-2-酮类化合物及其制备方法与应用 | |
| CN101157605A (zh) | 一种乙酰丙酮铜的生产方法 | |
| KR19990028872A (ko) | 알콜로부터 케톤 또는 알데하이드를 제조하는 방법 | |
| CN112341332A (zh) | 一种西他列汀关键中间体降解废弃物的回收利用方法 | |
| Anacardio et al. | Palladium-Catalyzed Selective Carbonylation of Vinyl Triflates in the Presence of 2-Iodophenols: A New Route to 3-Spiro-Fused Benzofuran-2 (3H)-ones | |
| US7112679B2 (en) | Convergent synthesis of α-aryl-β-ketonitriles | |
| Yang et al. | Gold‐catalyzed Cycloisomerization of 2‐Aryl‐2‐(arylamino)‐3‐butyn‐1‐ols toward 2‐(2′‐Aminoaryl)‐2, 5‐dihydrofurans | |
| Zang et al. | An efficient one‐pot synthesis of pyrazolone derivatives promoted by acidic ionic liquid | |
| Guo et al. | Iron (III)‐Catalyzed Difluoroalkylation of Aryl Alkynes with Difluoroenol Silyl Ether in the Presence of Trimethylsilyl Chloride | |
| CN111100042A (zh) | 一种2-甲氧基-5-磺酰胺基苯甲酸的制备方法 | |
| Zhou et al. | Electrochemical Cyclization of α, β‐Alkynic Hydrazones and Primary Amines for the Synthesis of 3‐Alkynyltriazoles | |
| CN114436767B (zh) | 一种基于醋酸锌催化羰基还原制备醇类化合物的方法 | |
| CN111620824B (zh) | 一种以芳香醛为底物合成喹唑啉类化合物的方法 | |
| CN118496155A (zh) | 一种氮杂环并环丙烷类化合物及其制备方法和应用 | |
| CN108569969A (zh) | 一种间氨基苯乙炔的合成方法 | |
| CN116283972A (zh) | 一种3-取代中氮茚衍生物的制备方法 | |
| Liu et al. | Construction of indolizine scaffolds from α, ω-alkynoic acids and α, ω-vinylamines via sequential-relay catalysis in “one pot” | |
| CN112028860A (zh) | 一种2-乙酰呋喃的合成方法 |